ProShare Advisors’s Sutro Biopharma STRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,441
| Closed | -$14K | – | 2179 |
|
|
2025
Q1 | $14K | Sell |
21,441
-5,520
| -20% | -$3.59K | ﹤0.01% | 2056 |
|
|
2024
Q4 | $49.6K | Buy |
26,961
+11,494
| +74% | +$21.1K | ﹤0.01% | 2177 |
|
|
2024
Q3 | $53.5K | Sell |
15,467
-849
| -5% | -$2.94K | ﹤0.01% | 1971 |
|
|
2024
Q2 | $47.8K | Buy |
16,316
+5,373
| +49% | +$15.7K | ﹤0.01% | 1756 |
|
|
2024
Q1 | $61.8K | Buy |
+10,943
| New | +$61.8K | ﹤0.01% | 1877 |
|
|
2023
Q4 | – | Sell |
-11,770
| Closed | -$40.8K | – | 1972 |
|
|
2023
Q3 | $40.8K | Buy |
11,770
+38
| +0.3% | +$132 | ﹤0.01% | 1730 |
|
|
2023
Q2 | $54.6K | Buy |
11,732
+1,402
| +14% | +$6.52K | ﹤0.01% | 1766 |
|
|
2023
Q1 | $47.7K | Sell |
10,330
-1,360
| -12% | -$6.28K | ﹤0.01% | 1677 |
|
|
2022
Q4 | $94.5K | Buy |
+11,690
| New | +$94.5K | ﹤0.01% | 1663 |
|
|
2022
Q2 | – | Sell |
-12,929
| Closed | -$105K | – | 2099 |
|
|
2022
Q1 | $105K | Sell |
12,929
-3,061
| -19% | -$24.9K | ﹤0.01% | 2021 |
|
|
2021
Q4 | $238K | Buy |
15,990
+576
| +4% | +$8.57K | ﹤0.01% | 1922 |
|
|
2021
Q3 | $291K | Sell |
15,414
-4,108
| -21% | -$77.6K | ﹤0.01% | 1575 |
|
|
2021
Q2 | $363K | Buy |
19,522
+4,611
| +31% | +$85.7K | ﹤0.01% | 1763 |
|
|
2021
Q1 | $339K | Buy |
14,911
+2,774
| +23% | +$63.1K | ﹤0.01% | 1722 |
|
|
2020
Q4 | $263K | Buy |
+12,137
| New | +$263K | ﹤0.01% | 1698 |
|